Recombinant Human Erythropoietin in the Prevention of Late Anemia in Intrauterine Transfused Neonates With Rh-isoimmunization

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of pediatric hematology/oncology

• Publication date

  2010-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MPH.0b013e3181cf444cPMID 20216236
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pediatric outcome in Rhesus hemolytic disease treated with and without intrauterine transfusion.

  2008cited by this paper
• Fetal Intravenous Immunoglobulin Therapy in Rhesus Hemolytic Disease

  2006cited by this paper
• Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn

  2003cited by this paper
• Late anaemia in Rh haemolytic disease

  2003cited by this paper
• Erythropoietin as Treatment for Late Hyporegenerative Anemia in Neonates with Rh Hemolytic Disease after in utero Exchange Transfusion

  2002cited by this paper
• SUCCESSFUL TREATMENT OF NEONATAL RHESUS HEMOLYTIC ANEMIA WITH HIGH DOSES OF RECOMBINANT HUMAN ERYTHROPOIETIN

  2001influential reference
• Late hyporegenerative anemia in neonates with rhesus hemolytic disease

  1999cited by this paper
• High‐dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice

  1999cited by this paper
• Recombinant Erythropoietin in the Prevention of Late Anaemia in Intrauterine Transfused Neonates with Rh-Haemolytic Disease

  1999influential reference
• The scientific basis of antenatal prophylaxis

  1998cited by this paper
• The prevention of Rh haemolytic disease of the fetus and newborn — general background

  1998cited by this paper
• Kooperative Studie zum Einfluss einer hochdosierten Immunglobulintherapie auf die Hyperbilirubinämie bei Rhesusinkompatibilität

  1996cited by this paper
• Erythropoietin Course in Newborns with Rh Hemolytic Disease Transfused and Not Transfused in Utero

  1996cited by this paper
• Management of Late Anemia in Rhesus Hemolytic Disease: Use of Recombinant Human Erythropoietin (A Pilot Study)

  1996influential reference
• Suppression of erythropoiesis by intrauterine transfusions in hemolytic disease of the newborn: use of erythropoietin to treat the late anemia.

  1993cited by this paper
• Recombinant erythropoietin as treatment for the late hyporegenerative anemia of Rh hemolytic disease.

  1992cited by this paper
• High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease.

  1992cited by this paper
• High-dose immune globulin therapy for hyperbilirubinemia-caused by Rh hemolytic disease

  1992cited by this paper
• Hyporegenerative anemia associated with intrauterine transfusion in rhesus hemolytic disease.

  1991cited by this paper
• Effects of intravascular, intrauterine transfusion on prenatal and postnatal hemolysis and erythropoiesis in severe fetal isoimmunization.

  1990cited by this paper
• Intrauterine intravascular transfusion for severe erythroblastosis fetalis: How much to transfuse?

  1990cited by this paper
• Late hyporegenerative anemia in Rh hemolytic disease.

  1989cited by this paper
• Rh disease: intravascular fetal blood transfusion by cordocentesis.

  1986cited by this paper
• ADCC (K‐Cell) Lysis of Human Erythrocytes Sensitized with Rhesus Alloantibodies

  1979cited by this paper
• [Hemolytic disease of newborn].

  1956cited by this paper
• ISOIMMUNIZATION IN PREGNANCY: ITS POSSIBLE BEARING ON THE ETIOLOGY OF ERYTHROBLASTOSIS FOETALIS

  1941cited by this paper

• Understanding, detecting, and managing the "late" anemia of hemolytic disease of the fetus and newborn.

  2025cites this paper
• Erythrokinetic mechanism(s) causing the “late anemia” of hemolytic disease of the fetus and newborn

  2024cites this paper
• Darbepoetin alfa to reduce transfusion episodes in infants with haemolytic disease of the fetus and newborn who are treated with intrauterine transfusions in the Netherlands: an open-label, single-centre, phase 2, randomised, controlled trial.

  2023cites this paper
• Conservative Management of Alloimmune Hemolysis and Cholestasis With Extreme Laboratory Abnormalities

  2021cites this paper
• Early-onset hypoproliferative anemia in an intrauterine-transfused neonate with severe Rh hemolytic disease.

  2021cites this paper
• The role of recombinant Human erythropoietin in neonatal anemia.

  2020cites this paper
• Haemolytic Disease of the Fetus and Newborn

  2020cites this paper
• Severe early-onset anemia disproportionate to hyperbilirubinemia in a Rh isoimmunized neonate

  2020cites this paper
• Severe Late-onset Anemia Associated with Rhesus D Alloimmunization

  2020cites this paper
• Updates in Neonatal Hematology: Causes, Risk Factors, and Management of Anemia and Thrombocytopenia.

  2019cites this paper
• Case 1: Cardiac Arrest in a 2-month-old Boy with a Prenatal Course Complicated by Alloimmunization

  2019cites this paper
• Neonatal management and outcome in alloimmune hemolytic disease

  2017cites this paper
• Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn.

  2015cites this paper
• Effects of intravenous human immunoglobulin on late hyporegenerative anemia secondary to rhesus hemolytic disease of the newborn

  2014cites this paper
• Contemporary Uses of Erythropoietin in Pregnancy: A Literature Review

  2013cites this paper
• Spezielle Arzneimitteltherapie in der Schwangerschaft

  2013cites this paper
• Anti-Rh(c), “Little C,” Isoimmunization: The Role of rHuEpo in Preventing Late Anemia

  2013cites this paper
• Fetal Intrauterine Transfusion Therapy: Neonatal Outcomes

  2012cites this paper
• Neonatal management and outcome in red cell alloimmunization

  2012cites this paper
• Hematological morbidity and management in neonates with hemolytic disease due to red cell alloimmunization.

  2011influential citation
• The Effectiveness of Recombinant Human Erythropoietin (EPO) Treatment in a Neonate with Hyporegenerative Anemia Following Rh Isoimmunization in Spite of Normal Serum Epo Level

  2011cites this paper
• Erythropoietin and retinopathy of prematurity.

  2011cites this paper
• Eritropoyetina: más allá de la proliferación y maduración eritroide

  2010cites this paper